Author

Hiroyuki Maguchi

Institution: Teine Keijinkai Hospital

Observed institution: Teine Keijinkai Hospital

OpenAlex ID: A5143781452

Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial

2019 · Morihisa Hirota, Tooru Shimosegawa, et al. · Journal of Gastroenterology · 54

Works count: 1

Citation count: 54

H-index: 1

I10-index: 1